Ensign Peak Advisors’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.9M Sell
201,266
-16,441
-8% -$3.37M 0.07% 228
2025
Q4
$55.8M Sell
217,707
-59,366
-21% -$15.6M 0.1% 174
2025
Q3
$72.1M Buy
277,073
+38,533
+16% +$10.1M 0.12% 151
2025
Q2
$58.3M Sell
238,540
-135,690
-36% -$33.8M 0.1% 181
2025
Q1
$99M Sell
374,230
-31,227
-8% -$8.45M 0.19% 113
2024
Q4
$103M Sell
405,457
-319,796
-44% -$85.8M 0.18% 110
2024
Q3
$230M Sell
725,253
-57,049
-7% -$20.3M 0.4% 47
2024
Q2
$292M Buy
782,302
+264,346
+51% +$89.3M 0.53% 36
2024
Q1
$180M Buy
517,956
+43,065
+9% +$16.3M 0.33% 63
2023
Q4
$217M Sell
474,891
-126,561
-21% -$62.4M 0.43% 56
2023
Q3
$293M Buy
601,452
+38,724
+7% +$18.2M 0.62% 34
2023
Q2
$252M Buy
562,728
+68,748
+14% +$34.6M 0.51% 47
2023
Q1
$240M Sell
493,980
-40,259
-8% -$19.9M 0.52% 47
2022
Q4
$274M Buy
534,239
+142,262
+36% +$74.8M 0.62% 38
2022
Q3
$190M Sell
391,977
-32,763
-8% -$15.9M 0.47% 51
2022
Q2
$199M Buy
424,740
+41,885
+11% +$18.6M 0.47% 52
2022
Q1
$167M Sell
382,855
-64,756
-14% -$27.1M 0.34% 66
2021
Q4
$208M Buy
447,611
+111,700
+33% +$49.4M 0.4% 62
2021
Q3
$131M Buy
335,911
+32,203
+11% +$13.7M 0.27% 92
2021
Q2
$134M Buy
303,708
+141,113
+87% +$61.6M 0.27% 96
2021
Q1
$68.2M Sell
162,595
-10,154
-6% -$4.05M 0.15% 140
2020
Q4
$70.9M Sell
172,749
-66,973
-28% -$27.8M 0.16% 131
2020
Q3
$99.2M Buy
239,722
+18,730
+8% +$7.53M 0.25% 79
2020
Q2
$85.7M Sell
220,992
-313
-0.1% -$117K 0.23% 90
2020
Q1
$69.5M Buy
221,305
+104,836
+90% +$35.4M 0.23% 86
2019
Q4
$42.7M Buy
+116,469
New +$36.9M 0.11% 150

Other funds holding HUM

Ensign Peak Advisors's HUM Position: Q1 2026 in Review

Ensign Peak Advisors reduced its Humana (HUM) stake by 7.6% in Q1 2026, selling an estimated $3.37M and leaving 201,266 shares worth $34.9M. The position accounts for 0.07% of the portfolio, ranked #228.

Ensign Peak Advisors first reported a position in HUM in Q4 2019 and has held it in 26 quarters since. The position peaked at $293M in Q3 2023. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Ensign Peak Advisors held 201,266 shares of Humana worth $34.9M as of Q1 2026.
  • Ensign Peak Advisors sold 16,441 Humana shares in Q1 2026, an estimated $3.37M.
  • Humana made up 0.07% of Ensign Peak Advisors's portfolio in Q1 2026, its #228 holding.
  • Ensign Peak Advisors first reported a position in Humana in Q4 2019 and has held it in 26 quarters since.
  • Ensign Peak Advisors's Humana position peaked at $293M in Q3 2023.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Ensign Peak Advisors's 13F filing for Q1 2026, filed 13 May 2026.